Community reacts to Trump’s plan to improve kidney care
Described by HHS Secretary Alex M. Azar II as possibly the most significant step for treating kidney disease since Congress approved legislation in 1973 to create the ESRD Program, President Donald J. Trump signed an executive order this week to launch Advancing American Kidney Health, a new initiative to increase earlier intervention in chronic kidney care, incentivize dialysis providers…
Akebia Therapeutics CEO, John P. Butler, Elected Chair of Kidney Care Partners
Akebia Therapeutics, Inc. (AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, today announced that John P. Butler, President and Chief Executive Officer of Akebia, has been elected Chair of Kidney Care Partners (KCP), the nation’s largest kidney care coalition comprised of patient advocates, dialysis professionals, care providers,…
CMS announces 5 new payment models aimed at kidney care
The Trump administration Wednesday unveiled five new payment models aimed at transforming kidney care—including one that would be mandatory for some providers. The End-Stage Renal Disease (ESRD) Treatment Choices model will launch Jan.1. The Centers for Medicare & Medicaid Services (CMS) announced that certain ESRD treatment facilities and clinicians who manage care for beneficiaries with this…
HHS Unveils Kidney Care Revamp Including Mandatory, Voluntary Models
President Donald Trump on Wednesday (July 10) issued an executive order calling for demonstrations to revamp the kidney care sector, and HHS immediately released a mandatory pay model and multiple voluntary pay models to do so. “The state of care for patients with chronic kidney disease and end-stage renal disease (ESRD) is unacceptable: too many…
Trump’s executive order on kidney health lifts dialysis company stocks
“The executive order includes many of the recommendations from an industry advocacy group called Kidney Care Partners, which includes almost three dozen members such as the American Kidney Fund, Amgen, DaVita and Fresenius. A similar outline of ideas can also be found in a bill sponsored by Sens. Benjamin Cardin (D-MD) and Roy Blunt (R-MO)…
Trump’s executive order on kidney health lifts dialysis company stocks
“The executive order includes many of the recommendations from an industry advocacy group called Kidney Care Partners, which includes almost three dozen members such as the American Kidney Fund, Amgen, DaVita and Fresenius. A similar outline of ideas can also be found in a bill sponsored by Sens. Benjamin Cardin (D-MD) and Roy Blunt (R-MO)…
Kidney Care Partners Calls On CMS, Lawmakers To Reform ESRD Policies
Kidney Care Partners calls for a legislative and regulatory overhaul of renal disease treatment, including changes to the Medicare end-stage renal disease prospective payment system, an expansion of the Medicare Kidney Disease Education benefit, an extension of Medigap access for those with kidney disease and an HHS study on the social, behavioral and biological factors…
Kidney Care Partners releases new blueprint to prioritize kidney care
Advocacy group Kidney Care Partners has released a new plan outlining its vision for the future of kidney care in the United States. The organization said Kidney Care First: A Framework for Improving Renal Disease Support & Treatment is a blueprint for care that addresses the kidney disease cycle — from prevention to transplant. “The kidney care…
Proposed bipartisan kidney legislation takes on kidney disease epidemic in America
It wasn’t that long ago that kidney disease was considered a terminal illness. The first successful kidney transplant occurred just 69 years ago and the first dialysis clinic opened 12 years later. Our health care system took longer to respond – it was another decade before a Medicare program was established to help pay for…
Legislators introduce bill to improve access to CKD, ESKD care
Two U.S. senators recently introduced legislation to improve access to care for patients with chronic kidney disease. Sens. Ben Cardin (D-Md.) and Roy Blunt (R-Mo.) introduced S.1676, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2019, on May 24. “If passed, this legislation would raise awareness, incentivize innovation, improve care and empower…